Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Mesenchymal stromal cell therapy in ischemic heart disease

Research output: Contribution to journalJournal articleResearchpeer-review

  1. 30-day mortality in frail patients undergoing cardiac surgery: the results of the frailty in cardiac surgery (FICS) copenhagen study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Relationship Between Invasive Hemodynamics and Liver Function in Advanced Heart Failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Atrial fibrillation and anticoagulation in patients with breast cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Contemporary practice of CRT implantation in scandinavia compared to Europe

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Continuous-flow LVADs in the Nordic countries: complications and mortality and its predictors

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Prognosis and Reclassification by YKL-40 in Stable Coronary Artery Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Evaluation of computed tomography myocardial perfusion in women with angina and no obstructive coronary artery disease

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Although, treatment of ischemic heart disease (IHD) has improved considerably within the last decades, it is still the main cause of death worldwide. Despite maximum treatment, many IHD patients suffer from refractory angina and heart failure, which severely limits their daily lives. Moreover, IHD is very costly for the health care system. Therefore, new treatment options and strategies are being researched intensely. Stem cell therapy to improve myocardial perfusion and stimulate growth of new cardiomyocytes could be a new way to go. Nevertheless, the results from clinical studies have varied considerably, probably due to the use of many different cell lines obtained from different tissues and the different patient populations. The present review will focus on treatment with the mesenchymal stromal cell from bone marrow and adipose tissue in animal and patients with acute and chronic IHD (CIHD).

Original languageEnglish
JournalScandinavian cardiovascular journal : SCJ
Volume50
Issue number5-6
Pages (from-to)293-299
Number of pages7
ISSN1401-7431
DOIs
Publication statusPublished - 7 Jul 2016

ID: 49799725